GRANITE vs. control in all treated population (HR=0.73 [90% CI, 0.44, 1.21]) -- -- 50% relative risk reduction of progression ...

Shares of Gritstone bio Inc. (GRTSQ) have been struggling lately and have lost 87.3% over the past four weeks. However, a ...

Gritstone also has a vaccine for KRAS-driven tumors in Phase 2 development. The company is also developing an HIV vaccine with Gilead Sciences ( GILD ), according to its website. More on Gritstone bio ...

Gritstone Oncology ( (GRTS)) has shared an update. Gritstone bio, Inc., a biotech firm specializing in potent vaccines, has voluntarily filed for Chapter 11 bankruptcy to restructure and preserve ...

Two dozen firms looked at the company before it filed for bankruptcy protection. Leaders of Gritstone Bio Inc. could read the writing on the wall: Financial times for drug developers are tough and ...

There is a small hill high on the moors in Sheffield that - for the effort - gives the best walk in the Peak District.

Gritstone bio shares are trading lower by 64% during Thursday's session. The company announced it voluntarily filed for Chapter 11 restructuring. Gritstone bio Inc. GRTS shares are trading lower ...

Gritstone bio, Inc. (NASDAQ:GRTS), a biotechnology company, has disclosed a significant reduction in its workforce and the impending delisting of its common stock from the Nasdaq Stock Market.

EMERYVILLE, Calif.--(BUSINESS WIRE)--Gritstone bio, Inc. (Nasdaq: GRTS) (“Gritstone” or the “Company”), a clinical-stage biotechnology company working to ...

Northern Gritstone, the new investment business focused on university spin-outs in the north of England, today announces a first close of £215m having seen strong interest from investors in its ...

This is a summary of a request from Gritstone bio to hire Fenwick & West as special corporate counsel, filed Oct. 23 with the U.S. Bankruptcy Court in Delaware.